Reporting requirements during COVID-19 pandemic for controlled drugs

NHSE have written to advise you that with immediate effect, and for the foreseeable future, we have made the following changes to their normal processes

Access to End of Life Care Medication in Tower Hamlets

Further information, including a table with details on these pharmacies and their location.

Ibuprofen and COVID-19 symptoms - findings from safety review

The Commission on Human Medicines’ Expert Working Group on coronavirus (COVID-19) has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen, or other nonsteroidal anti-inflammatory drugs (NSAIDs), and contracting or worsening of COVID19.

BHR important update on children and young people and Nebulisers

Some parents and carers have been purchasing Nebulisers for use by their children at home. It is vital to avoid the temptation of prescribing nebules in this case without a clinical assessment of need as issuing them when not absolutely necessary is increasing risk.

Specialty-specific guidance on aspects of clinical care and treatment for COVID-19

Links to clinical and medications guidance from professional bodies for 17 medical specialities.

Guidance for end of life care - how to manage symptomatic patients

Guidance for End of Life Care - COVID 19

Your role in maintaining the medicines supply chain

GP and Pharmacies should not support patients trying to stockpile: these actions may put a strain on the supply chain and exacerbate any potential shortages.

BHR - Prescribing of paracetamol

In response to a number of queries regarding issuing prescriptions for paracetamol or ibuprofen for use during the current COVID-19 pandemic, GP practices are advised to continue prescribing in line with the existing BHR CCGs’ position.